Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Amble vs AquaVita NextGen

Amble
Graded #212

Higher grade

vs+9.5
AquaVita NextGen
Graded #415

Lower grade

The verdict

Amble takes it — 65.8/100 to 56.3/100.

Amble grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmble +38
61
23
Dose & formulationAquaVita NextGen +11
64
75
Clinical oversightAquaVita NextGen +3
79
82
Labs & monitoringAquaVita NextGen +1
52
53
FulfillmentAmble +19
81
62
Contract termsAmble +8
55
47
Amble · left barAquaVita NextGen · right bar

The numbers

MetricAmbleAquaVita NextGen
WeighScore65.8/10056.3/100
GradeCC
Scorecard rank#212#415
Semaglutide$179/mo (starting dose, compounded)$375/mo (first-month rate, compounded)
Tirzepatide$289/mo (starting dose, compounded)$320/mo (starting dose, 3-month plan, compounded)
CoverageAll 50 states5 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Amble

Graded #212 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
AquaVita NextGen

Graded #415 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard